Avisi Technologies has released positive 12-month clinical data on the VisiPlate Aqueous Shunt from the VITA Trial. The VITA ...

Nova Eye Medical Ltd (($ELXMF)) announced an update on their ongoing clinical study. Study Overview: Nova Eye Medical Ltd is conducting a clinical ...

Through 24 months, scleral bio-reinforced cyclodialysis combined with cataract surgery lowered IOP by enhancing uveoscleral outflow, according to a study published in Ophthalmology Science. "The ...

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Kin Sheng Lim, MD, discusses a randomized controlled trial on endoscopic cyclophotocoagulation, or ECP, for primary open-angle ...

Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, presented positive twelve-month clinical data on VisiPlate® Aqueous Shunt from the VITA Trial ...

Canaloplasty has emerged as a viable surgical intervention for the management of open-angle glaucoma, offering an alternative to traditional procedures such as trabeculectomy. This non-penetrating ...

Proactive strategies in glaucoma care, including minimally invasive glaucoma surgery (MIGS) and physician decision-making, ...

iDose TR (travoprost intracameral implant) is a long duration prostaglandin analog approved for a single administration and indicated for the reduction of intraocular pressure (IOP) in patients with ...

Sight Sciences’ management is scheduled to present at the Stifel 2025 Healthcare Conference on Tuesday, November 11, 2025 at 8:20 am PT / 11:20 am ET. Sight Sciences’ management is scheduled to ...

Not all glaucoma cases are the same. There are actually several types of glaucoma, and your treatment will depend on what type of glaucoma you have. A small percentage of people with glaucoma have a ...

Carol A. Cates, MSN, MBA, RN, NEA-BC, is the chief nursing officer at Odessa Regional Medical Center. You can reach her via e-mail at [email protected] Several years ago, my husband was in an accident ...